ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.79% to 6772.90.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.21% to 6826.90.
After plenty of volatility for the ResMed Inc (ASX:RMD) share price, the healthcare company has released its FY24 first quarter update.
Here are 3 things I wish I knew about life and business at 23. For investors, this simply means: pessimism can work, from time to time. But over the long run — better on a brighter future is much, much, much better bet.
Will Ozempic sink ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL)? Will Tesla’s Cyber Truck come to Australia? The Australian Investors Podcast explains…
The local share market snapped its losing streak, with both the All Ordinaries (INDEXASX: XAO) and S&P/ASX200 (INDEXASX: XJO) gaining 0.4% on a settling of bond yields and the latest Reserve Bank meeting minutes.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.037% to 7091.00.
Sonic Healthcare Ltd (ASX: SHL) has traditionally viewed as an ASX share that provides a mixture of dividends and defensive growth for investors. However, SHL shares have been sold off 17% over the last 6 months.
The Australia share market retreated to a six-month low on Tuesday, as global markets felt the pressure from surging bond yields – despite, in Australia’s case, the Reserve Bank leaving the official cash rate on hold at 4.1 per cent, for a fifth straight month.
